Black Diamond Therapeutics, Inc. (BDTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BDTX. The 7-day demo opens the 1M and 3M ranges and puts BDTX on your watchlist.
Start 7-day demoLatest BDTX insider trades
Ali Behbahani - DirectorGrant or award$15K- Prakash Raman - DirectorGrant or award$13K
- Ali BehbahaniGrant or award
About Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. files with the SEC under CIK 0001701541 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
BDTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 14,508 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BDTX insider transactions (Form 4)
2222 Form 4 filings on record, the earliest from Dec 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ali Behbahani - Director | Grant or award | Common Stock | 7,707 | $1.93 footnote F2 | $15K | |
| ||||||
| Prakash Raman - Director | Grant or award | Common Stock | 6,801 | $1.93 footnote F2 | $13K | |
| ||||||
| Ali Behbahani | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
 Samarth Kulkarni | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Garry E. Menzel | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Prakash Raman | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
 Kapil Dhingra | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Shannon Campbell | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Ali Behbahani | Grant or award | Common Stock | 8,961 | $1.66 footnote F2 | $15K | |
| ||||||
| Prakash Raman | Grant or award | Common Stock | 7,907 | $1.66 footnote F2 | $13K | |
| ||||||
| Ali Behbahani | Grant or award | Common Stock | 6,919 | $2.15 footnote F2 | $15K | |
| ||||||
| Prakash Raman | Grant or award | Common Stock | 6,105 | $2.15 footnote F2 | $13K | |
| ||||||
| Erika Jones - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
 Brent Hatzis-Schoch - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Elizabeth Buck - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Sergey Yurasov - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Mark A. Velleca - Officer | Grant or award | Stock Option (Right to Buy) | 600,000 | $0.00 | - | |
| Prakash Raman | Grant or award | Common Stock | 3,843 | $3.35 | $13K | |
| Ali Behbahani | Grant or award | Common Stock | 4,291 | $3.35 | $14K | |
| Prakash Raman | Grant or award | Common Stock | 5,150 | $2.50 | $13K | |
| Shannon Campbell | Grant or award | Common Stock | 4,500 | $2.50 | $11K | |
| Ali Behbahani | Grant or award | Common Stock | 5,750 | $2.50 | $14K | |
BDTX insider trading FAQ
What is the latest insider trade for BDTX?
Black Diamond Therapeutics, Inc. (BDTX) had 2 insider filings in the last 90 days, with the most recent on 2026-09-21. The full record for BDTX runs to 22 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BDTX stock?
No insider purchases of BDTX were filed in the last 90 days.
How many insiders are selling BDTX stock?
No insider sales of BDTX were filed in the last 90 days.
Where can I see BDTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BDTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ali Behbahani view on EDGAR
- - Prakash Raman view on EDGAR
- - Ali Behbahani view on EDGAR
- - Samarth Kulkarni view on EDGAR
- - Garry E. Menzel view on EDGAR
- - Prakash Raman view on EDGAR
- - Kapil Dhingra view on EDGAR
- - Shannon Campbell view on EDGAR
- - Ali Behbahani view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BDTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BDTX with a 7-day demo
- BDTX on your watchlist
- Every BDTX Form 4 filing on record
- Up to 3 months of BDTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
